Skip to main content
MTI Ltd. logo

MTI Ltd. — Investor Relations & Filings

Ticker · 9438 ISIN · JP3167480007 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 89 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country JP Japan
Listing T 9438

About MTI Ltd.

https://www.mti.co.jp/eng/

MTI Ltd. is a technology company that develops and distributes content and services primarily for mobile platforms. The company's operations are structured into several key business segments: Healthcare, Content, and School DX (Digital Transformation). The Healthcare division offers health management services and applications, including the 'Lunaruna' suite of apps focused on women's health. The Content business provides digital media such as music through its 'music.jp' service, comics, and other entertainment materials. In the DX segment, MTI focuses on digital solutions for the education sector. The company also develops services in areas like fintech and weather information, aiming to connect people and information through technology.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 95% confidence The document is a formal certification (“確認書”) submitted under the Financial Instruments and Exchange Act confirming the accuracy of the half‐year report (“第31期中（自2025年10月１日至2026年３月31日）の半期報告書”). It contains no financial statements or substantive data, only officer attestation. Per the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the interim report itself.
2026-05-15 Japanese
半期報告書－第31期(2025/10/01－2026/03/31)
Interim / Quarterly Report Classification · 87% confidence The document is a Japanese 半期報告書 (semi‐annual report) filed under the Financial Instruments and Exchange Act, covering the 31st interim accounting period (October 1, 2025 to March 31, 2026). It contains full interim consolidated financial statements (balance sheet, cash flows), management’s discussion and analysis, segment results, and other detailed financial data. This fits the definition of a comprehensive interim/quarterly report rather than a simple announcement or earnings release. H1 2026
2026-05-15 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since this is a regulatory filing required by law to accompany financial reports and does not fit into specific categories like 10-K or IR, it is classified as a general regulatory filing.
2025-12-19 Japanese
有価証券報告書－第30期(2024/10/01－2025/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal header identifying the document type, the fiscal period (2024-10-01 to 2025-09-30), and the company name (MTI Ltd.). The presence of XBRL-like tags and detailed financial reporting structure confirms it is the full annual report rather than an announcement or summary. FY 2025
2025-12-19 Japanese
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau ('関東財務局長'). The submission reason explicitly states it is based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, which mandates filing for events causing a significant impact on the company's financial condition or operating results. The content details a resolution by the Board of Directors on May 23, 2025, to sell a portion of shares in a consolidated subsidiary (Pharmow Co., Ltd.), resulting in an expected gain on the sale of affiliated company shares (900 million JPY) to be recorded as extraordinary income in the non-consolidated third quarter results. This structure—a formal filing announcing a significant, non-routine corporate event (like a major asset sale or divestiture) that impacts financials—is characteristic of a significant event disclosure required under Japanese regulations, which often falls under the general 'Regulatory Filings' category when a more specific code like M&A (TAR) or Capital Change (CAP) is not a perfect fit. Since the core event is a divestiture/sale of a subsidiary stake resulting in a one-time gain, and it is filed as an 'Extraordinary Report' (which is a general disclosure mechanism), the most appropriate general regulatory filing code is RNS, as it is a mandatory, non-periodic regulatory disclosure that doesn't fit the other specific categories like ER, IR, or 10-K.
2025-05-27 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 30
2025-05-15 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.